clodronic acid has been researched along with Pericementitis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airaksinen, S; Juppo, AM; Rosenqvist, K; Vehkamäki, M | 1 |
| Deng, X; Endo, Y; Kiyoura, Y; Tamai, R | 1 |
| Aydın, S; Bozkurt, Ş; Gültekin, SE; Kurtiş, B; Ozdemir, SP; Sengüven, B; Tüter, G; Watanabe, K | 1 |
| Husa, V; Kivelä-Rajamäki, M; Maisi, P; Salo, T; Sorsa, T; Srinivas, R; Teronen, O; Tervahartiala, T | 1 |
| Ding, Y; Ingman, T; Konttinen, YT; Lauhio, A; Lindqvist, C; Salo, T; Santavirta, S; Sorsa, T; Teronen, O | 1 |
| Golub, LM; Heikkilä, P; Liu, Y; Llavaneras, A; Ramamurthy, NS; Rifkin, BR; Ryan, ME; Salo, T; Sorsa, T; Teronen, O | 1 |
| Golub, LM; Heikkilä, P; Llavaneras, A; Ramamurthy, NS; Rifkin, BR; Ryan, ME; Salo, T; Sorsa, T; Teronen, O | 1 |
| Abreu, AL; Alencar, VB; Bezerra, MM; Brito, GA; Lima, V; Ribeiro, RA; Rocha, FA | 1 |
| Horiuchi, H; Mitsuta, T; Shinoda, H | 1 |
| Rowe, DJ; Schmidt, LJ | 1 |
10 other study(ies) available for clodronic acid and Pericementitis
| Article | Year |
|---|---|
Evaluating optimal combination of clodronate and bioactive glass for dental application.
Topics: Alveolar Bone Loss; Bone Density Conservation Agents; Bone Substitutes; Calorimetry, Differential Scanning; Chemical Precipitation; Chemistry, Pharmaceutical; Clodronic Acid; Crystallography, X-Ray; Drug Combinations; Feasibility Studies; Glass; Humans; Hydrogen-Ion Concentration; Hydroxyapatites; Microscopy, Electron, Scanning; Particle Size; Periodontitis; Powder Diffraction; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical | 2014 |
Alendronate augments interleukin-1beta release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1.
Topics: Alendronate; Animals; Bacteroidaceae; Bone Density Conservation Agents; Caspase 1; Clodronic Acid; Dose-Response Relationship, Drug; Enzyme Activation; Interleukin-1beta; Macrophages; Mice; Periodontitis; Toll-Like Receptors | 2009 |
Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study.
Topics: Alveolar Bone Loss; Alveolar Process; Animals; Anti-Bacterial Agents; Biopsy; Bone Density Conservation Agents; Clodronic Acid; Diabetes Mellitus, Experimental; Doxycycline; Drug Therapy, Combination; Gingiva; Interleukin-1beta; Lymphocytes; Male; Matrix Metalloproteinase 9; Periodontitis; Rats; Rats, Wistar; Streptozocin; Tooth Mobility | 2012 |
Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
Topics: Adult; Aged; Aged, 80 and over; Alveolar Bone Loss; Anti-Bacterial Agents; Clodronic Acid; Dental Implants; Doxycycline; Enzyme Inhibitors; Female; Gingival Crevicular Fluid; Humans; Hydroxamic Acids; Male; Matrix Metalloproteinase 7; Matrix Metalloproteinase 8; Matrix Metalloproteinase Inhibitors; Middle Aged; Peptides, Cyclic; Periodontal Index; Periodontitis; Tetracyclines | 2003 |
Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate.
Topics: Adult; Anti-Bacterial Agents; Arthritis; Aurothioglucose; Biomarkers; Bone Remodeling; Bone Resorption; Calcium; Clodronic Acid; Collagenases; Connective Tissue Diseases; Dental Implants; Dental Restoration Failure; Dose-Response Relationship, Drug; Doxycycline; Enzyme Activation; Enzyme Inhibitors; Gingival Crevicular Fluid; Humans; Immunoblotting; Matrix Metalloproteinase 8; Matrix Metalloproteinase Inhibitors; Middle Aged; Osteolysis; Periodontal Diseases; Periodontal Ligament; Periodontitis; Tooth Mobility | 1997 |
CMT-8/clodronate combination therapy synergistically inhibits alveolar bone loss in LPS-induced periodontitis.
Topics: Alveolar Bone Loss; Animals; Clodronic Acid; Collagenases; Drug Synergism; Drug Therapy, Combination; Gelatinases; Gingiva; Lipopolysaccharides; Male; Periodontitis; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Tetracyclines; Tooth Mobility | 1999 |
A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Clodronic Acid; Drug Synergism; Drug Therapy, Combination; Gelatinases; Lipopolysaccharides; Male; Matrix Metalloproteinase Inhibitors; Pancreatic Elastase; Periodontitis; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Tetracyclines; Tooth Loss | 2001 |
Disodium chlodronate prevents bone resorption in experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Clodronic Acid; Male; Periodontitis; Rats; Rats, Wistar; Statistics, Nonparametric | 2002 |
Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis.
Topics: Acid Phosphatase; Administration, Topical; Alveolar Bone Loss; Analysis of Variance; Animals; Antimetabolites; Azo Compounds; Biomarkers; Bone Density; Bone Resorption; Cell Count; Clodronic Acid; Coloring Agents; Disease Models, Animal; Eosine Yellowish-(YS); Fluorescent Dyes; Injections; Isoenzymes; Male; Maxillary Diseases; Methyl Green; Molar; Osteoclasts; Periodontitis; Radiography; Rats; Rats, Wistar; Statistics as Topic; Tartrate-Resistant Acid Phosphatase | 2002 |
The effects of diphosphonates on alveolar bone loss.
Topics: Animals; Bone Resorption; Clodronic Acid; Diphosphonates; Disease Models, Animal; Female; Male; Periodontitis; Rats | 1987 |